Covered recipient · General Payments record
MONIKA PRASAD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,646.69
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $585.61 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $298.25 | 22 |
| SK Life Science, Inc. | $181.35 | 3 |
| Celgene Corporation | $61.35 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $22.56 | 1 |
| UCB, Inc. | $22.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.40 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307286 | CMS |
| ABBVIE INC. | $15.00 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307291 | CMS |
| ABBVIE INC. | $9.69 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307295 | CMS |
| ABBVIE INC. | $12.86 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307299 | CMS |
| ABBVIE INC. | $19.09 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307303 | CMS |
| ABBVIE INC. | $13.53 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307307 | CMS |
| ABBVIE INC. | $18.54 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307310 | CMS |
| ABBVIE INC. | $12.36 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307315 | CMS |
| ABBVIE INC. | $12.61 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307319 | CMS |
| ABBVIE INC. | $20.91 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307322 | CMS |
| ABBVIE INC. | $18.54 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307327 | CMS |
| ABBVIE INC. | $10.37 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307331 | CMS |
| ABBVIE INC. | $11.97 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307335 | CMS |
| ABBVIE INC. | $12.56 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307339 | CMS |
| ABBVIE INC. | $9.91 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307343 | CMS |
| ABBVIE INC. | $27.72 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307347 | CMS |
| ABBVIE INC. | $10.91 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307351 | CMS |
| ABBVIE INC. | $15.61 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307355 | CMS |
| ABBVIE INC. | $12.70 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307359 | CMS |
| ABBVIE INC. | $9.74 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307363 | CMS |
| ABBVIE INC. | $3.12 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307367 | CMS |
| ABBVIE INC. | $8.11 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105307371 | CMS |
| Celgene Corporation | $20.55 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101139172 | CMS |
| Celgene Corporation | $18.31 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101139174 | CMS |
| Celgene Corporation | $22.49 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101139176 | CMS |
| Novartis Pharmaceuticals Corporation | $22.56 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087341031 | CMS |
| SK Life Science, Inc. | $122.65 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154138042 | CMS |
| SK Life Science, Inc. | $26.99 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154137960 | CMS |
| SK Life Science, Inc. | $31.71 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154138054 | CMS |
| UCB, Inc. | $22.10 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143217007 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.